Physician profile
Robert Tilley
NPI 1962504886
$1,613.43
in general payments reported to CMS, 2019-2025
10 companies · $407 in 2025
The $407 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.93 · 2021: $18.10 · 2022: $14.12 · 2023: $423 · 2024: $737 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $928 · Travel and Lodging: $489 · Consulting Fee: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $928.48 |
| Travel and Lodging | $488.80 |
| Consulting Fee | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $488.80 | 2024 | |
| Glaxosmithkline, LLC. | $470.28 | 2023-2024 | Nucala, Arexvy, Trelegy Ellipta |
| Inspire Medical Systems, INC. | $315.81 | 2023-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $201.35 | 2019-2025 | |
| Philips North America LLC | $39.65 | 2024-2025 | Vest Therapy Und, (8874) Incourage |
| Avadel Cns Pharmaceuticals, LLC | $24.11 | 2025 | Lumryz |
| Harmony Biosciences LLC | $22.65 | 2025 | |
| Resmed Corp | $18.10 | 2021 | |
| Lilly USA, LLC | $16.35 | 2025 | Zepbound |
| Astrazeneca Pharmaceuticals Lp | $16.33 | 2025 | Breztri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Tilley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.